BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16431259)

  • 1. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.
    Winkelmayer WC; Charytan DM; Levin R; Avorn J
    Am J Kidney Dis; 2006 Feb; 47(2):301-8. PubMed ID: 16431259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
    J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
    Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population.
    Amin AP; Mukhopadhyay E; Nathan S; Napan S; Kelly RF
    Transl Res; 2009 Aug; 154(2):78-89. PubMed ID: 19595439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H; Searles G; Gillis A
    Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
    Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elderly patients undergoing major vascular surgery: risk factors and medication associated with risk reduction.
    Feringa HH; Bax JJ; Karagiannis SE; Noordzij P; van Domburg R; Klein J; Poldermans D
    Arch Gerontol Geriatr; 2009; 48(1):116-20. PubMed ID: 18177954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
    Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME; Bouvy ML; de Blaey CJ; de Boer A
    Clin Ther; 2005 Nov; 27(11):1806-14. PubMed ID: 16368451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.
    Mancini GB; Etminan M; Zhang B; Levesque LE; FitzGerald JM; Brophy JM
    J Am Coll Cardiol; 2006 Jun; 47(12):2554-60. PubMed ID: 16781387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of beta-blocker therapy in older patients after acute myocardial infarction in Ontario.
    Rochon PA; Anderson GM; Tu JV; Clark JP; Gurwitz JH; Szalai JP; Lau P
    CMAJ; 1999 Nov; 161(11):1403-8. PubMed ID: 10906894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of medication therapy discontinuation on mortality after myocardial infarction.
    Ho PM; Spertus JA; Masoudi FA; Reid KJ; Peterson ED; Magid DJ; Krumholz HM; Rumsfeld JS
    Arch Intern Med; 2006 Sep; 166(17):1842-7. PubMed ID: 17000940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy after myocardial infarction: disease management versus usual care.
    Chan V; Cooke CE
    Am J Manag Care; 2008 Jun; 14(6):352-8. PubMed ID: 18554073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.